Biogen Inc.BIIBNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank14
3Y CAGR-13.4%
5Y CAGR-16.4%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-13.4%/yr
vs -16.3%/yr prior
5Y CAGR
-16.4%/yr
Recent acceleration
Acceleration
+2.9pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.88B | -24.6% |
| 2024 | $2.49B | +18.7% |
| 2023 | $2.10B | -27.4% |
| 2022 | $2.89B | +3.5% |
| 2021 | $2.79B | -39.2% |
| 2020 | $4.59B | -34.8% |
| 2019 | $7.04B | +19.6% |
| 2018 | $5.89B | +10.2% |
| 2017 | $5.35B | +3.8% |
| 2016 | $5.15B | - |